Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
ESLA
Fundamentals

Estrella Immunopharma, Inc.

ESLA

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

3.14M
▼-594.37k▼-15.91%
3 Months Change

Liabilities

3.00M
▲8.19k▲0.2739%
3 Months Change

Free Cash Flow

0.00
0.000.00%
-

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-08-20
Form 8-K
ID: 0001213900-24-071174
2024-08-06
Form 8-K
ID: 0001213900-24-065292
2024-07-02
Form 8-K
ID: 0001213900-24-058085
2024-05-15
Form 10-Q
ID: 0001213900-24-043126
2024-05-13
Form 8-K
ID: 0001213900-24-042444
2024-04-10
Form 8-K
ID: 0001213900-24-031716
2024-03-11
Form 8-K
ID: 0001213900-24-021186
2024-03-07
Form 8-K
ID: 0001213900-24-020566
2024-02-14
Form 10-Q
ID: 0001213900-24-014191
2024-02-02
Form 8-K
ID: 0001213900-24-009325